Please note: The information displayed on this page might be outdated.
MedTrace: Developed several novel safety features, which combined will revolutionize blood flow imaging in PET. The solution (MT-100) automates bedside production and infusion of the tracer O-15 H2O (gold standard). MT-100 (planned launch in 2019) will outperform alternative tracers on accuracy, efficiency and safety. Initial focus on cardiology and subsequently the technology platform can be applied to oncology, neurology and endocrinology.
Diagnostics, Medical Device
Company Participants at Danish Science and The City DKBIO 17
- Martin Stenfeldt, CEO
- Rune Wiik Kristensen, CSO & Co-Founder